The null results of the current study where blood glucose levels were not very different between treatment groups are consistent with the hypothesis that it is the relationship between Hp phenotype and glycemic control that affects risk of CAD; however, further research is needed to determine if these results are conclusive. Here, HP is linked to coronary artery disorder.